Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormones and homocysteine.

S Asnani1, C Desouza, J Homan

  • 1Department of Medicine, Section of Endocrinology, Tulane University School of Medicine, New Orleans, LA, USA.

Minerva Endocrinologica
|July 2, 2002
PubMed
Summary

High homocysteine levels (hyperhomocysteinemia) are a risk factor for cardiovascular disease (CVD). Hormonal factors and endocrine disorders like diabetes influence these levels, impacting CVD risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing total knee arthroplasty recovery: the role of enhanced recovery after surgery (ERAS) protocols on clinical outcomes and patient satisfaction.

Musculoskeletal surgery·2025
Same author

Botanical repositories for Indian medicinal plants: A unified harmonisation approach to authentication, quality control, and conservation.

Journal of ethnopharmacology·2025
Same author

Dimensions of wisdom perception across twelve countries on five continents.

Nature communications·2024
Same author

Exploring Scientific Validation of Millets in Contemporary Healthcare: A Traditional Food Supplement.

Recent advances in food, nutrition & agriculture·2024
Same author

Testing the NASA BioSentinel Pixel Dosimeter Using Gamma-ray and Neutron Sources at the LLNL Calibration Lab.

Health physics·2022
Same author

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed-ratio combination: a post hoc analysis of the LixiLan-O and LixiLan-L trials.

Diabetic medicine : a journal of the British Diabetic Association·2019

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Metabolic Disorders

Background:

  • Hyperhomocysteinemia is a known risk factor for cardiovascular disease (CVD).
  • Plasma homocysteine concentrations are influenced by genetic, nutritional, hormonal, and lifestyle factors.
  • Hormonal modulation of homocysteine metabolism is implicated in CVD pathogenesis, though mechanisms are not fully understood.

Purpose of the Study:

  • To review homocysteine metabolism and its hormonal determinants.
  • To discuss the role of hyperhomocysteinemia in diabetes mellitus and other endocrine disorders.
  • To explore the complex association between hyperhomocysteinemia and cardiovascular risk in specific patient populations.

Main Methods:

  • Literature review of studies on homocysteine metabolism.

Related Experiment Videos

  • Analysis of hormonal influences on homocysteine levels.
  • Examination of the relationship between hyperhomocysteinemia, endocrine disorders, and cardiovascular disease.

    • Main Results:

    • Various factors, including hormones, influence homocysteine metabolism and CVD risk.
    • The link between hyperhomocysteinemia and diabetes mellitus is complex and contributes to unexplained CVD risk in diabetics.
    • Insulin's role in homocysteine metabolism is debated, despite its effect on relevant enzymes.

    Conclusions:

    • Hormonal factors significantly modulate homocysteine metabolism and may contribute to cardiovascular disease development.
    • Understanding the interplay between hyperhomocysteinemia, endocrine disorders, and CVD is crucial for risk assessment and management.
    • Further research is needed on the impact of homocysteine-lowering interventions on cardiovascular outcomes.